Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nuvation Bio Inc. Class A Common Stock
(NY:
NUVB
)
8.780
+0.260 (+3.05%)
Streaming Delayed Price
Updated: 11:47 AM EST, Dec 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,489,286
Open
8.610
Bid (Size)
8.780 (1,500)
Ask (Size)
8.790 (2,200)
Prev. Close
8.520
Today's Range
8.570 - 8.885
52wk Range
1.540 - 8.952
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
December 03, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio to Participate in Upcoming Investor Conferences
November 26, 2025
From
Nuvation Bio
Via
Business Wire
Performance
YTD
+239.0%
+239.0%
1 Month
+88.0%
+88.0%
3 Month
+169.3%
+169.3%
6 Month
+390.5%
+390.5%
1 Year
+212.5%
+212.5%
More News
Read More
Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut
↗
November 20, 2025
Via
Stocktwits
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
November 19, 2025
Via
MarketMinute
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
4 Analysts Assess Nuvation Bio: What You Need To Know
↗
September 30, 2025
Via
Benzinga
Which stocks are moving on Wednesday?
↗
November 19, 2025
Via
Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
November 19, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 19, 2025
Via
Benzinga
Analyst Expectations For Nuvation Bio's Future
↗
September 08, 2025
Via
Benzinga
Nuvation Bio (NUVB) Q3 2025 Earnings Transcript
↗
November 04, 2025
Via
The Motley Fool
Topics
Earnings
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 03, 2025
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock
↗
November 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Nuvation Bio to Participate in Upcoming Investor Conferences
October 30, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma
October 23, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025
October 20, 2025
From
Nuvation Bio
Via
Business Wire
Why Nuvation Bio Stock Is Skyrocketing Today
↗
September 30, 2025
Via
The Motley Fool
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday
↗
September 30, 2025
Via
Benzinga
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
September 30, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
September 19, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer
September 07, 2025
From
Nuvation Bio
Via
Business Wire
Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday
↗
September 05, 2025
Via
Benzinga
Top 2 Health Care Stocks That May Plunge This Month
↗
September 05, 2025
Via
Benzinga
Nuvation Bio to Participate in Upcoming Investor Conferences
August 27, 2025
From
Nuvation Bio
Via
Business Wire
NUVB Sales Jump 1,043% on Drug Launch
↗
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Nuvation Bio Inc. Class A Common Stock publicly traded?
Yes, Nuvation Bio Inc. Class A Common Stock is publicly traded.
What exchange does Nuvation Bio Inc. Class A Common Stock trade on?
Nuvation Bio Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Nuvation Bio Inc. Class A Common Stock?
The ticker symbol for Nuvation Bio Inc. Class A Common Stock is NUVB on the New York Stock Exchange
What is the current price of Nuvation Bio Inc. Class A Common Stock?
The current price of Nuvation Bio Inc. Class A Common Stock is 8.780
When was Nuvation Bio Inc. Class A Common Stock last traded?
The last trade of Nuvation Bio Inc. Class A Common Stock was at 12/18/25 11:47 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today